AstraZeneca (AZ) has announced that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) has been approved ...

Alnylam Pharmaceuticals’ RNAi therapeutic vutrisiran has been recommended by the European Medicines Agency’s human medicines ...

The relationship between patient advocacy groups (PAGs) and pharmaceutical companies face challenges that if addressed could ...

Bristol Myers Squibb (BMS) has announced that an injectable version of its cancer immunotherapy Opdivo (nivolumab) has been ...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care ...